Skip to main content
Clinical Trials/NCT03281928
NCT03281928TerminatedNot Applicable

Effect of Dietary Sodium and Potassium Citrate on Renal Mineral Handling

University of Chicago1 site in 1 country30 target enrollmentStarted: October 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
30
Locations
1
Primary Endpoint
Urine Calcium levels

Study Overview

Brief Summary

This study intends to characterize the affect of sodium and potassium citrate in the diet on renal function.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
Double (Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • age 18 - 70, approximately equal numbers of men and women
  • studied by endoscopy with complete papillary mapping and grading
  • stone formers

Exclusion Criteria

  • Patients with primary renal diseases or renal impairment (eGFR < 90), or medical conditions such as diabetes, or systemic diseases or medications that alter calcium metabolism
  • Patients with known bladder voiding problems

Arms & Interventions

High Sodium plus placebo

Placebo Comparator

Intervention: Placebo (Dietary Supplement)

Low Sodium plus Potassium Citrate

Experimental

Intervention: Sodium and Potassium Citrate (Dietary Supplement)

Low Sodium plus placebo

Placebo Comparator

Intervention: Placebo (Dietary Supplement)

High Sodium plus Potassium Citrate

Experimental

Intervention: Sodium and Potassium Citrate (Dietary Supplement)

Outcomes

Primary Outcomes

Urine Calcium levels

Time Frame: 10 days

Amount of calcium in the urine will be measured

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials